{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:22:06Z","timestamp":1779934926738,"version":"3.53.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.seizure.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:10:14Z","timestamp":1523362214000},"page":"72-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Eslicarbazepine acetate exposure in pregnant women with epilepsy"],"prefix":"10.1016","volume":"58","author":[{"given":"Raquel","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds M.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gra\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcio","family":"Soares-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seizure.2018.04.007_bib0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1756285615623934","article-title":"Management of epilepsy during pregnancy: an update","volume":"9","author":"Patel","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"10.1016\/j.seizure.2018.04.007_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/ern.12.32","article-title":"Second-generation antiepileptic drugs and pregnancy: a guide for clinicians","volume":"12","author":"Reimers","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.seizure.2018.04.007_bib0015","unstructured":"Aptiom. http:\/\/www.aptiom.com\/ipi\/prescribing-information.cfm. (Accessed 18 January 2016)."},{"key":"10.1016\/j.seizure.2018.04.007_bib0020","unstructured":"Zebinix\u00ae \u2013 Summary of Product Characteristics."},{"issue":"7","key":"10.1016\/j.seizure.2018.04.007_bib0025","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and epilepsy-related mortality in pregnancy","volume":"55","author":"Edey","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.04.007_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CLEP.S118336","article-title":"Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies","volume":"9","author":"Petersen","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.seizure.2018.04.007_bib0035","first-page":"349","article-title":"Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study","author":"Bech","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.seizure.2018.04.007_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.04.007_bib0045","doi-asserted-by":"crossref","unstructured":"Golembesky A, Cooney M, Craig J, et al., Outcomes following exposure to the antiepileptic drug lacosamide during pregnancy\u2013results from a global safety database, P5.231, 88 (16) 2017, http:\/\/n.neurology.org\/content\/88\/16_Supplement\/P5.231. [Accessed 29 March 2018].","DOI":"10.1212\/WNL.88.16_supplement.P5.231"},{"key":"10.1016\/j.seizure.2018.04.007_bib0050","unstructured":"Vazquez B, Dobrinsky C, Yang H, et al. Review of pregnancies events in perampanel clinical studies, 1.192, 2015, https:\/\/www.aesnet.org\/meetings_events\/annual_meeting_abstracts\/view\/2321386. [Accessed 29 March 2018]."},{"issue":"5","key":"10.1016\/j.seizure.2018.04.007_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1185\/030079905X43640","article-title":"Safety of the newer antiepileptic drug oxcarbazepine during pregnancy","volume":"21","author":"Montouris","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.seizure.2018.04.007_bib0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1528-1167.2006.00459.x","article-title":"Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium","volume":"47","author":"Mazzucchelli","year":"2006","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111830027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111830027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:50:59Z","timestamp":1761011459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111830027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":12,"alternative-id":["S105913111830027X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.04.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eslicarbazepine acetate exposure in pregnant women with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}